ANDY: That’s exactly right. That’s exactly right. So the more people we have on 23andMe and the more people that consent to research, we have over eighty percent today, that engage in the questions and answers which means we have this huge collection of phenotypic information. So we have genetic information, phenotypic information, and the combination of those things leads to drug targets. Cause in our database we can see well who knew that that particular gene is associated with those diseases. And it’s only at scale, meaning millions of people that we can determine that.